Browse the latest research summaries in the field of covid-19 for spinal cord injury patients and caregivers.
Showing 71-80 of 81 results
European Journal of Trauma and Emergency Surgery, 2021 • July 22, 2020
This study analyzed the impact of the COVID-19 quarantine on traumatic brain injury (TBI) cases in Tyrol, Austria, by comparing data from the 2020 lockdown period with the same period in 2016–2019. Th...
KEY FINDING: The weekly number of TBI patients decreased significantly during the strict quarantine in 2020 compared to 2016, 2018, and 2019.
Cell Discovery, 2021 • January 1, 2021
This study comprehensively investigates pathophysiological and immunological changes in healthy volunteers after COVID-19 vaccination with an inactivated SARS-CoV-2 vaccine. The findings reveal consis...
KEY FINDING: Vaccination with an inactivated SARS-CoV-2 vaccine induces consistent alterations in hemoglobin A1c, serum sodium and potassium levels, coagulation profiles, and renal functions.
VIEW, 2022 • March 2, 2022
This study reveals that acidosis-related pH promotes SARS-CoV-2 infection by increasing ACE2 expression on the cell membrane, suggesting a positive feedback loop where SARS-CoV-2 infection-induced aci...
KEY FINDING: Acidosis-related pH (6.8) increases the expression of SARS-CoV-2 receptor ACE2 on the cell membrane.
Diagnostics, 2022 • October 22, 2022
The study analyzed 189 convalescent plasma (CP) donations from 66 donors to determine the optimal time span for CP donation based on anti-SARS-CoV-2 anti-S IgG antibody levels. It found a significant ...
KEY FINDING: There is a significant correlation between semi-quantitative SARS-CoV-2 IgG ratio values and in vitro antibody functionality.
International Journal of Infectious Diseases, 2023 • January 10, 2023
This study comprehensively analyzed the prevalence, severity, and characteristics of smell and taste alterations (STAs) in patients infected with the SARS-CoV-2 Omicron variant. The findings suggest t...
KEY FINDING: The prevalence of smell and taste alterations did not significantly decrease during the Omicron dominance compared to earlier phases of the pandemic.
BMC Infectious Diseases, 2023 • November 14, 2023
This study aimed to determine the rate of post-COVID-19 syndrome (PCS) among SARS-CoV-2 seropositive blood donors and to investigate the role of Epstein-Barr virus (EBV) reactivation in PCS. The resul...
KEY FINDING: 18% of individuals with asymptomatic or mild SARS-CoV-2 infections experienced PCS symptoms lasting up to one year.
Cell Reports Medicine, 2024 • May 21, 2024
The study analyzes the transcriptome and DNA methylome of fetal germline cells following maternal SARS-CoV-2 infection, finding that infection at early gestational age trivially affects fetal germ cel...
KEY FINDING: Maternal SARS-CoV-2 infection has trivial impacts on fetal germ cell (FGC) development during early gestation, a critical period for germ cell specification and epigenetic reprogramming.
Brain and Spine, 2025 • December 9, 2024
The study investigated the impact of COVID-19 lockdowns and restrictions on the incidence of traumatic brain injuries (TBI) in Tyrol, Austria, comparing TBI rates during lockdown periods in 2020 and 2...
KEY FINDING: During the first lockdown in the winter of 2020/2021, there was a notably lower incidence of moderate and severe TBIs compared to the corresponding period in 2019/2020 (p = 0.016).
Cytotherapy, 2020 • May 2, 2020
This statement addresses the potential use of mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) as a therapeutic approach for COVID-19, highlighting both the promise and the potential ...
KEY FINDING: MSC-EVs do not necessarily suppress immune responses, but rather modulate them, specifically moderating acute immune responses toward regulatory responses, inducing tolerance, and restoring homeostasis.
STEM CELLS AND DEVELOPMENT, 2020 • May 20, 2020
This letter to the editor critically assesses a published study on the use of bone marrow mesenchymal stem cell-derived exosomes (ExoFlo) for treating severe COVID-19. The authors express concerns reg...
KEY FINDING: The letter identifies a lack of information regarding the characterization, biological properties, and therapeutic actions of the ExoFlo product used in the original study.